The Safety and Efficacy of Antifibrinolytic Therapy in Neonatal Cardiac Surgery

• Chih-Yuan Lin,

  Affiliations Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America, Division of Cardiovascular Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Jeffery H. Shuhaiber,

  Affiliation Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Hugo Loyola,

  Affiliation Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Hua Liu,

  Affiliation Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Pedro del Nido,

  Affiliation Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• James A. DiNardo,

  Affiliation Department of Anaesthesia, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Frank A. Pigula

  * E-mail: frank.pigula@cardio.chboston.org

  Affiliation Department of Cardiac Surgery, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯